Inactive Instrument
Acura Pharmaceuticals, Inc. Stock Nasdaq
Stocks
US00509L7038
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 3.28M 2.83M 2.65M 2.42M 4.56M 313M 4.57M 31.43M 12.26M 158M 12.31M 12.04M 524M | P/E 2020 |
-5.25x | P/E 2021 | -25x |
|---|---|---|---|---|---|
| Enterprise Value | 3.41M 2.94M 2.76M 2.52M 4.74M 326M 4.76M 32.72M 12.77M 165M 12.82M 12.54M 546M | EV / Sales 2020 |
2.91x | EV / Sales 2021 | 20.9x |
| Free-Float |
98.31% | Yield 2020 * |
-
| Yield 2021 | - |
| 1 day | +7.77% |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Jones
CEO | Chief Executive Officer | 67 | 2011-03-31 |
Bob Seiser
DFI | Director of Finance/CFO | 62 | 2024-07-31 |
Albert Brzeczko
CTO | Chief Tech/Sci/R&D Officer | 69 | 2009-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
William Skelly
CHM | Chairman | 75 | 1996-09-30 |
| Director/Board Member | 55 | 2002-11-30 | |
Bruce Wesson
BRD | Director/Board Member | 83 | 1998-02-28 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +7.77% | +5.17% | - | - | 6.73K | |
| -1.59% | -3.35% | +64.49% | +98.69% | 69.54B | |
| -1.34% | -0.75% | +48.56% | +90.63% | 64.97B | |
| -8.37% | -12.43% | +0.14% | -15.42% | 25.64B | |
| -2.35% | -5.75% | -12.17% | +448.29% | 25.89B | |
| +0.30% | -0.69% | +63.18% | +11.93% | 26.51B | |
| -0.96% | +10.36% | +278.86% | +438.78% | 20.22B | |
| -0.51% | +0.23% | +33.71% | -18.02% | 19.98B | |
| -1.91% | -4.37% | +13.33% | +531.29% | 15.69B | |
| -1.47% | +0.68% | +43.67% | +145.49% | 13.49B | |
| Average | -1.04% | -1.93% | +59.31% | +192.41% | 31.33B | |
| Weighted average by Cap. | -1.93% | -1.50% | +57.15% | +152.82% |
| 2020 | 2021 | |
|---|---|---|
| Net sales | 3.57M 3.08M 2.88M 2.63M 4.96M 341M 4.98M 34.22M 13.35M 172M 13.4M 13.11M 571M | 1.56M 1.35M 1.26M 1.15M 2.17M 149M 2.18M 14.98M 5.85M 75.41M 5.87M 5.74M 250M |
| Net income | -1.21M -1.04M -976K -891K -1.68M -115M -1.68M -11.58M -4.52M -58.28M -4.54M -4.44M -193M | -879K -757K -710K -648K -1.22M -84.01M -1.23M -8.43M -3.29M -42.41M -3.3M -3.23M -141M |
| Net Debt | 5.86M 5.05M 4.73M 4.32M 8.14M 560M 8.16M 56.13M 21.9M 283M 21.99M 21.51M 937M | 135K 116K 109K 99.57K 188K 12.9M 188K 1.29M 505K 6.51M 507K 496K 21.6M |
Employees
-
